Małgorzata Waluś‐Miarka

Refinement of Variant Selection for the LDL Cholesterol Genetic Risk Score in the Diagnosis of the Polygenic Form of Clinical Familial Hypercholesterolemia and Replication in Samples from 6 Countries

Marta Futema, Sonia Shah, Jackie Cooper et al. · Clinical Chemistry · 2014 · 212 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Plasma Asymmetric Dimethylarginine (ADMA) Is Associated With Retinopathy in Type 2 Diabetes

Maciej T. Małecki, Anetta Undas, Katarzyna Cyganek et al. · Diabetes Care · 2007 · 61 citations · Full text

Medicine, Biochemistry, Pharmacology +10

Retinopathy in type 2 diabetes mellitus is associated with increased intima‐media thickness and endothelial dysfunction

Grzegorz Osmenda, Małgorzata Waluś‐Miarka, Jan Skupień et al. · European Journal of Clinical Investigation · 2008 · 58 citations

Medicine, Clinical Sciences, Ophthalmology +15

Total plasma homocysteine correlates in women with gestational diabetes

Barbara Idzior−Waluś, Katarzyna Cyganek, Krystyna Sztefko et al. · Archives of Gynecology and Obstetrics · 2008 · 43 citations

Medicine, Endocrinology, Obstetrics +12

The genetic spectrum of familial hypercholesterolemia in south-eastern Poland

Mahtab Sharifi, Małgorzata Waluś‐Miarka, Barbara Idzior−Waluś et al. · Metabolism · 2015 · 34 citations · Full text

Life Sciences, Genetics, Molecular Genetics +16